A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home Therapies Neural Stimulation Archive for category "Vagus Nerve Stimulation" (Page 2)
formats

CerebralRx FitNeS Vagus Nerve Stimulator for Epilepsy Treatment

In June 2011, Israeli neuromodulation systems developer BioControl Medical spun-off CerebralRx to market its FitNeS vagus nerve stimulation system for the treatment of refractory epilepsy. The FitNes system employs platform technology developed for the CardioFit® system for treating congestive heart failure (HF). CerebralRx spun out of BioControl Medical to expand the use of this technology outside of cardiology for the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on CerebralRx FitNeS Vagus Nerve Stimulator for Epilepsy Treatment  comments 
formats

Cyberonics’ Vagus Nerve Stimulators

Cyberonics was founded in Houston, TX in 1987 to develop an implantable device for the treatment of epilepsy.  In July 1997, The FDA approved the VNS Therapy System (formerly known as the NCP® NeuroCybernetic Prosthesis System) as an adjunctive epilepsy treatment for adults and children over 12 years of age with partial onset seizures refractory to

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cyberonics’ Vagus Nerve Stimulators  comments 
formats

AIMD Companies Founded by Yossi Gross

Yossi Gross (born February 5, 1947) is an Israeli medical device innovator and entrepreneur. His medical-device companies are incubated through Rainbow Medical. Currently, the following companies led by Yossi Gross are focusing on active implantable medical devices: BetaStim, developing a new neurostimulation treatment for diabetes Brainsgate, developing an implantable device for acute stroke treatment and brain

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on AIMD Companies Founded by Yossi Gross  comments